Aug 6 2013
TTY BIOPHARM was awarded "Outstanding Company of the Year", the highest award given at the Bio Taiwan 2013 Exhibition. At the opening ceremony on July 18, Rong-Jing Lin, Chairman and General Manager of TTY BIOPHARM, received the prize from Ma Ying-jeou, President of Taiwan.
Bio Taiwan 2013, held at Taipei World Trade Center's Nangang Exhibition Hall on July 18-21, featured 520 companies in biotech, pharmaceutical, healthcare and equipment and raw material sectors from around the world. Combining exhibitions, conferences, luncheons, symposia and BioBusiness Asia for the first time, the event attracted international professionals from Germany, Switzerland, the US, Canada, Singapore, Japan, Australia, South Korea, India and Israel.
TTY BIOPHARM stood out for its remarkable operating results, stable and rapid growth, as well as outstanding performance in R&D and its contributions to industry growth, evidenced by the 61 overseas drug licenses and 46 patents the company has obtained to date. During the last decade, TTY BIOPHARM has been aggressively seeking expansion and looking for international partners. The company has demonstrated much higher growth potential than its competitors, while maintaining focus on new drug research and technology innovation and deepening its reach into the oncology sector. This was one of the key factors for which the firm has received high recognition from the judging panel as a role model for the biotech industry.
Source:
TOT Biopharm Company Limited